Schweizerischer Nationalfonds / Fonds national suisse
"Developing antibiotics is not profitable, hence the crucial role of universities."
mehr
Storys zum Thema Pharmaindustrie
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
mehrStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
mehrSchweizerischer Nationalfonds / Fonds national suisse
The tumour hacker
mehrSchweizerischer Nationalfonds / Fonds national suisse
Breath analysis to monitor health status in intensive care
mehr- 4
FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX
mehr
Artilysin® - A Groundbreaking "Green Pharma" Solution
mehrAstrasana and Clever Leaves Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
mehrAmicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
mehrDEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES
mehrFDI World Dental Federation: Prescribing of dental antibiotics up 22% in England during first year of COVID-19 / Prescriptions of all other antibiotics fell during the same period
mehrZur Rose and KPT together launch digital medicines assistant Medi+
mehr
1